Raymond James reiterates Outperform on Plexus stock at $275 target
Raymond James maintained an Outperform rating on Plexus Corp. (PLXS) with a $275 price target. The stock has risen 51% in the past year but is currently trading above its Fair Value estimate. The firm met with Plexus executives and expressed incremental positivity about its growth visibility and competitive positioning. Plexus reported record fiscal fourth-quarter earnings of $2.84 per share on revenue of $1.43 billion, exceeding estimates.
How this was made
The 30-second read
Why it matters
Analyst reiteration may provide a modest catalyst for short‑term buying interest, but no new corporate action is disclosed.
Market read
The piece offers limited new trading insight; it mainly restates existing earnings performance and analyst opinion.
What to watch
Potential supply-chain constraints in semiconductor equipment could limit near‑term margin expansion.
Background
The article recaps Plexus Corp.'s recent fiscal Q4 earnings beat and Raymond James' analyst coverage, adding a $275 price target.
Ticker impact
Raymond James reiterated an Outperform rating on Plexus Corp. (PLXS) with a $275 price target, noting recent earnings beat and margin concerns.
potential upward pressure as the $275 target exceeds current price
The rating is unchanged but the high target may attract buyers seeking upside, though margin weakness tempers enthusiasm.
Market effects
The reiteration highlights ongoing scrutiny of semiconductor capital equipment and aerospace/defense exposure.
Limited to U.S. investors tracking PLXS.
Minimal; primarily affects PLXS shareholders.
Counterpoint
The high target may be overly optimistic given weak gross margins and modest growth visibility.
Key entities
- Analyst FirmRaymond James
Provided the Outperform rating and $275 price target for PLXS.
- CompanyPlexus Corp.
Manufacturer of semiconductor capital equipment and aerospace/defense components.




